20cm速递｜科创创业ETF（588360）涨超2.2%，科技企业IPO回暖或提振板块估值

Group 1 - Yunshen Technology announced the completion of nearly 500 million yuan financing, having implemented over 600 industry projects, with founder Zhu Qiuguo being an associate professor at Zhejiang University [1] - Xinda Biologics launched its GCG/GLP-1 dual-target weight loss drug, Masitide, priced between Semaglutide and Tirzepatide, suitable for obese patients with fatty liver [1] - Four departments jointly proposed a target to exceed 100,000 domestic high-power charging facilities by the end of 2027, while Changxin Storage initiated listing guidance to further promote the construction of technology industry infrastructure [1] Group 2 - Shenwan Hongyuan Securities noted that in the first half of 2025, new stocks in the Sci-Tech Innovation and Entrepreneurship 50 index were mainly concentrated in manufacturing sectors such as power equipment, automotive, electronics, and machinery, with the automotive sector accounting for 28% of fundraising [1] - Continuous policy support for technology companies to issue and list shares has been observed, with reforms in the Sci-Tech Innovation Board and the resumption of listing standards for unprofitable companies, expanding the applicable scope [1] - As of the end of June, there were 11 unprofitable companies under review in the Sci-Tech Innovation and Entrepreneurship sector, primarily in the medical and IT industries, with 2 having passed the review [1] - The average first-day price-to-earnings (PE) ratio for new stocks in the Shanghai and Shenzhen markets in the first half of 2025 was 20 times (30 times for the Sci-Tech Innovation Board), at a low since the implementation of the registration system, but the proportion of oversubscribed projects and the oversubscription ratio both increased, indicating upward pricing pressure [1] Group 3 - The Sci-Tech Innovation and Entrepreneurship ETF tracks the Sci-Tech Innovation and Entrepreneurship 50 Index, which can have a daily fluctuation of up to 20%, reflecting the overall performance of innovative growth companies in China's capital market [2] - The index covers multiple strategic emerging industries, including information technology, pharmaceuticals, and new energy, showcasing the comprehensive trends of listed companies in these sectors [2]